Sheridan, United States – Sept 29, 2026 – The OsteoIQ Bone Turnover Marker Bundle gives individuals a way to track bone remodeling activity at 3, 6, or 12-month intervals, starting at $269, with results delivered through the Bone Health Intelligence app.

OsteoIQ, a direct-to-consumer bone health platform, today announced an expanded focus on CTX and P1NP bone turnover marker testing, giving users worldwide a repeatable, at-home method for monitoring bone remodeling activity. The OsteoIQ Bone Turnover Marker Bundle, starting at $269, is designed for individuals who want more than a single data point and for healthcare practitioners who need objective, interval-based bone health data to inform their recommendations.

What’s Being Offered and Why It Matters Bone health monitoring has traditionally been structured around a DXA scan every one to two years. That scan gives you a bone mineral density number at a specific moment in time. It doesn’t tell you whether bone remodeling is currently tipped toward loss or toward building, and it can’t reflect whether recent changes to nutrition, supplementation, or lifestyle are doing anything.

That’s the gap CTX and P1NP testing is built to address.

CTX (C-terminal telopeptide) is a marker of bone resorption, reflecting how actively the body is currently breaking down existing bone tissue. P1NP (procollagen type I N-terminal propeptide) is a marker of bone formation, reflecting how actively new bone is being produced. When tracked together over repeated intervals, these two markers offer a picture of current bone remodeling balance that a density scan alone doesn’t capture. The two tests work as a pair: one showing what’s being lost, the other showing what’s being built.

Testing through OsteoIQ can be completed at home, with intervals of 3, 6, or 12 months depending on the user’s monitoring goals. Every purchase includes access to the Bone Health Intelligence app, which translates test results into personalized, data-driven insights designed to support ongoing bone health management.

Who This Is For This approach is most relevant for people who’ve already been told their bone density is below where it should be and want to know, in the coming months rather than years, whether their current habits are moving things in the right direction. It’s also relevant for individuals with a family history of osteoporosis who want to monitor their bone remodeling activity before a scan indicates a problem.

Healthcare practitioners are another key audience. Rather than waiting on a scheduled DXA, practitioners can use interval-based bone turnover marker data to make more timely, objective recommendations for their patients.

One honest note: bone turnover markers are leading indicators, not diagnostic tools. They reflect current remodeling activity, and interpreting significant changes is best done in conversation with a qualified healthcare provider who knows your full picture. OsteoIQ’s platform is built to support that conversation, not replace it. The Broader OsteoIQ Ecosystem

Beyond biomarker testing, OsteoIQ offers the Optimal Genomics test, starting at $379, which explores genetic factors including vitamin D metabolism, calcium absorption, and an individual’s personal osteoporosis risk picture. For users who want to understand both what their body is doing right now and what their genetics suggest about their long-term bone health, the two tests together form what OsteoIQ calls an all-in-one approach to Bone Health Intelligence.

The Bone Health Intelligence app connects both data streams, delivering insights that are specific to the user’s results rather than generic guidance about calcium and vitamin D.

The Real Cost of Waiting Skipping bone marker testing doesn’t save money. It trades a known cost for an unknown one. Twelve to twenty-four months of not knowing whether current efforts are working means that same time is potentially lost if they aren’t. The OsteoIQ model is built around closing that feedback loop at intervals that are actually useful for making adjustments, not just confirming damage after the fact.

The Bone Turnover Marker Bundle is available now through OsteoIQ’s website, with worldwide availability and testing intervals selected at the time of purchase.

About OsteoIQ

OsteoIQ is a direct-to-consumer bone health platform offering at-home bone turnover marker and genomics testing, with results delivered through the proprietary Bone Health Intelligence app. Available worldwide, OsteoIQ’s testing model is built around repeatable monitoring at 3, 6, or 12-month intervals. OsteoIQ combines biomarker testing, genetic insights, and data-driven tools to support proactive bone health management for individuals and the healthcare practitioners who work with them.

Media Contact
Company Name: OsteoIQ
Contact Person: Media Relations
Email: Send Email
Phone: +1 855 856 9986
City: Sheridan, WY
Country: United States
Website: https://osteoiq.com

Media gallery

About The Author
OsteoIQ